Japan addresses language barriers in international drug quality audits by employing bilingual auditors, providing translation services, and utilizing standardized documentation in English. Training programs enhance language proficiency, while collaboration with international regulatory bodies ensures clear communication. These strategies facilitate effective audits and compliance with global pharmaceutical standards.
